Related Experiment Videos
Determinants of parathormone secretion in primary hyperparathyroidism
M Paillard1, J P Gardin, P Borensztein
1Faculté de Médecine Broussais-Hôtel Dieu, Université Pierre-et-Marie-Curie, INSERM CJF n. 88-07, Paris, France.
Hormone Research
|January 1, 1989
Summary
In primary hyperparathyroidism, calcium levels influence parathormone (PTH) secretion. Calcitriol effectively suppresses PTH, offering a potential therapeutic target for managing hypercalcemia.
Area of Science:
- Endocrinology
- Calcium Metabolism
- Parathyroid Hormone Regulation
Background:
- Primary hyperparathyroidism (PHPT) is characterized by elevated parathormone (PTH) and calcium levels.
- The interplay between plasma calcium, PTH secretion, and calcitriol in PHPT requires further elucidation.
Purpose of the Study:
- To investigate the impact of acute plasma calcium changes on PTH secretion in PHPT patients.
- To explore the role of calcitriol in modulating PTH hypersecretion and its association with disease presentation.
Main Methods:
- Studied 23 PHPT patients, assessing PTH secretion during acute plasma calcium modifications using Na2EDTA infusions.
- Correlated basal plasma calcium with maximal serum PTH(1-84) and set point values.
- Measured serum calcitriol levels in patients with renal stone versus bone disease presentations.
Main Results:
- In autonomous PHPT, higher basal calcium correlated with maximal PTH secretion.
- In suppressible PHPT, higher basal calcium correlated with an elevated PTH set point.
- Patients with renal stones had higher calcitriol and moderate PTH, while those with bone disease had lower calcitriol and high PTH.
- Intravenous calcitriol administration suppressed PTH hypersecretion without altering ionized calcium.
Conclusions:
- Hypercalcemia in PHPT is linked to the magnitude of PTH secretion or set point error.
- Calcitriol plays a significant role in regulating PTH secretion, potentially serving as a therapeutic agent for PHPT.